Margaret C. Skokan
43 works · 2,097 citations · h-index 13
Top works
- Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients
- Identifying and Targeting ROS1 Gene Fusions in Non–Small Cell Lung Cancer
- MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients
- Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients
- Correlations between the percentage of tumor cells showing an anaplastic lymphoma kinase (ALK) gene rearrangement, ALK signal copy number, and response to crizotinib therapy in ALK fluorescence in situ hybridization–positive nonsmall cell lung cancer
- Genetic Abnormalities of the EGFR Pathway in African American Patients With Non–Small-Cell Lung Cancer
- Fluorescence In situ Hybridization Subgroup Analysis of TRIBUTE, a Phase III Trial of Erlotinib Plus Carboplatin and Paclitaxel in Non–Small Cell Lung Cancer
- EGFR and HER2 Genomic Gain in Recurrent Non-small Cell Lung Cancer After Surgery: Impact on Outcome to Treatment with Gefitinib and Association with EGFR and KRAS Mutations in a Japanese Cohort
- Native and rearranged ALK copy number and rearranged cell count in non–small cell lung cancer
- Increased SOX2 Gene Copy Number Is Associated with FGFR1 and PIK3CA Gene Gain in Non-Small Cell Lung Cancer and Predicts Improved Survival in Early Stage Disease
- Genetic stability of bone marrow-derived human mesenchymal stromal cells in the Quantum System
- Standardisation of EGFR FISH in colorectal cancer: results of an international interlaboratory reproducibility ring study
- Fluorescence in situ hybridization (FISH) subgroup analysis of TRIBUTE, a phase III trial of erlotinib plus carboplatin and paclitaxel in NSCLC
- Evidence for cell fusion is absent in vascular lesions associated with pulmonary arterial hypertension
- Effect of increased MET gene copy number on survival of surgically resected non-small cell lung cancer (NSCLC) patients
- Native and rearranged ALK copy number and rearranged ALK cell count in NSCLC: Implications for ALK inhibitor therapy.
- SOX2 and FGFR1 gene copy number in surgically resected non-small cell lung cancer (NSCLC).
- A5-01: Epidermal growth factor receptor (EGFR) gene amplification in non-small cell lung cancer (NSCLC): molecular patterns and sensitivity to tyrosine kinase inhibitors
- Standardization of EGFR FISH in colorectal cancer: Results of an international, interlaboratory reproducibility ring study.
- Changes in molecular profile following platinum chemotherapy in NSCLC.